NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.620
+0.020 (1.25%)
Jul 31, 2026, 4:00 PM EDT - Market closed
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $172.39 million as of July 31, 2026. Its market cap has decreased by -5.61% in one year.
Market Cap
172.39M
Enterprise Value
160.53M
1-Year Change
-5.61%
Ranking
Category
Stock Price
$1.62
ChartMarket Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $172.39M, an increase of 360.56%. That is a compound annual growth rate of 23.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 172.39M | -61.32% |
| Dec 31, 2025 | 445.73M | 190.81% |
| Dec 31, 2024 | 153.27M | 26.05% |
| Dec 29, 2023 | 121.60M | 74.14% |
| Dec 30, 2022 | 69.83M | -27.73% |
| Dec 31, 2021 | 96.62M | 58.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camp4 Therapeutics | 176.81M |
| Immunic | 176.13M |
| Jyong Biotech | 175.19M |
| Armata Pharmaceuticals | 174.74M |
| Innate Pharma | 171.23M |
| AN2 Therapeutics | 170.72M |
| Alector | 170.42M |
| Humacyte | 170.06M |